AVXL
ANAVEX LIFE SCIENCES CORP.
NASDAQ · Healthcare · Biotechnology · US
$1.36
+8.80%Next report
Analyst consensus
- Next report date
- Nov 24, 2026
- EPS estimate
- -$0.11
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 25, 2026
- EPS actual
- -$0.03
- EPS estimate
- -$0.08
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +13.7%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 25, 2026 | -$0.08 | -$0.03 | Beat 62.50% | — |
| Jun 30, 2026 | -$0.07 | -$0.07 | In line | — |
| Nov 25, 2025 | -$0.13 | -$0.11 | Beat 15.38% | — |
| Aug 12, 2025 | -$0.13 | -$0.16 | Miss -23.08% | — |
| Feb 12, 2025 | -$0.17 | -$0.14 | Beat 17.65% | — |
| Dec 23, 2024 | -$0.17 | -$0.14 | Beat 17.65% | — |
| May 9, 2024 | -$0.13 | -$0.13 | In line | — |
| Feb 7, 2024 | -$0.15 | -$0.11 | Beat 26.67% | — |
| Nov 27, 2023 | -$0.16 | -$0.12 | Beat 25.00% | — |
| Feb 7, 2023 | -$0.20 | -$0.17 | Beat 15.00% | — |
| Nov 28, 2022 | -$0.16 | -$0.18 | Miss -12.50% | — |
| Aug 9, 2022 | -$0.15 | -$0.16 | Miss -6.67% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 24, 2026